SCHEMBL660144

SCHEMBL660144

COc1ccc(N2CCN(c3c(C)c4c(c(C(C)O)c3C)OC(C)(C)C4)CC2)cc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.42
ALDH1A1 P00352 4/20 0.40
GAA P10253 2/20 0.40
HTT P42858 1/20 0.40
DRD2 P14416 1/20 0.40
AKR1C3 P42330 1/20 0.40
HTR1A P08908 1/20 0.38
POLB P06746 2/20 0.38
KMT2A Q03164 4/20 0.38
MEN1 O00255 3/20 0.37
LMNA P02545 3/20 0.37
MAPT P10636 2/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GFER P55789 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL658597 0.86 DRD2 (0.46) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL660132 0.84 DRD2 (0.44) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL659005 0.83 DRD2 (0.43) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL657655 0.82 ALDH1A1 (0.46) L3MBTL1ALDH1A1GAAHTTAKR1C3
SCHEMBL658823 0.81 ALDH1A1 (0.39) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL660722 0.81 DRD2 (0.43) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL1723343 0.80 ALDH1A1 (0.42) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL661493 0.79 DPP4 (0.34) L3MBTL1ALDH1A1GAAHTTAKR1C3
SCHEMBL660201 0.79 DRD2 (0.45) L3MBTL1ALDH1A1GAAHTTDRD2
SCHEMBL659723 0.77 PKM (0.41) L3MBTL1ALDH1A1GAAHTTDRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8957069-B2 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-02-17 US disclosed
US-8957069-B2 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-02-17 US disclosed
US-8957069-B2 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2015-02-17 US disclosed
EP-2781513-A1 Benzofuran derivatives Takeda Pharmaceutical Company Limited (JP) 2014-09-24 EP disclosed
EP-2406243-B1 BENZOFURAN DERIVATIVES TAKEDA PHARMACEUTICAL (JP) 2014-05-07 EP disclosed
US-8288390-B2 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-10-16 US disclosed
US-8288390-B2 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-10-16 US disclosed
US-8288390-B2 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-10-16 US disclosed
US-20120232096-A1 BENZOFURAN DERIVATIVES TSUKAMOTO TETSUYA (JP) 2012-09-13 US disclosed
US-20120232095-A1 BENZOFURAN DERIVATIVES TSUKAMOTO TETSUYA (JP) 2012-09-13 US disclosed
US-20120232095-A1 BENZOFURAN DERIVATIVES TSUKAMOTO TETSUYA (JP) 2012-09-13 US disclosed
US-20120232095-A1 BENZOFURAN DERIVATIVES TSUKAMOTO TETSUYA (JP) 2012-09-13 US disclosed
US-20120232096-A1 BENZOFURAN DERIVATIVES TSUKAMOTO TETSUYA (JP) 2012-09-13 US disclosed
US-20120232096-A1 BENZOFURAN DERIVATIVES TSUKAMOTO TETSUYA (JP) 2012-09-13 US disclosed
US-20120046277-A1 BENZOFURAN DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-02-23 US disclosed
US-20120046277-A1 BENZOFURAN DERIVATIVES TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2012-02-23 US disclosed
US-20100234357-A1 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
US-20100234357-A1 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed
US-20100234357-A1 Benzofuran derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-09-16 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120232096-A1 BENZOFURAN DERIVATIVES AHR, BRPF3, CBR3 L3MBTL1 2934/4885ALDH1A1 618/4885GAA 4738/4885
US-20100234357-A1 Benzofuran derivatives AHR, BRPF3, CBR3 L3MBTL1 2934/4885ALDH1A1 618/4885GAA 4738/4885
US-20120232095-A1 BENZOFURAN DERIVATIVES AHR, BRPF3, CBR3 L3MBTL1 2934/4885ALDH1A1 618/4885GAA 4738/4885
US-20120046277-A1 BENZOFURAN DERIVATIVES BRPF3, BRD1, CBR3 L3MBTL1 2266/4885ALDH1A1 1010/4885GAA 4790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.